Skip to content

IDEX Corp

US · IEX #1045 by market cap Listed 1970
219.64 -7.37 -3.25%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 6 in the most recent period (2026/Q4).
  • Total institutional ownership rose 0.3 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
102.07% +0.31pp
Institutions
910 -6
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund81.09%
Hedge Fund11.33%
Public Company3.30%
Government Pension Fund2.11%
Private Company1.40%
Sovereign Wealth Fund1.38%
Corporate Pension Plan0.60%
Family Office/Trust0.26%
Endowment Fund0.24%
Insurance Company0.23%

Top holders as of 2026-09-30

BlackRock 7.76% · 5.70M sh
Vanguard Capital Management, LLC 7.13% · 5.23M sh
Vanguard Portfolio Management, LLC 5.05% · 3.71M sh
State Street Global Advisors 4.59% · 3.37M sh
PRIMECAP Management Company 4.49% · 3.30M sh
Eaton Vance Management 2.96% · 2.18M sh
Geode Capital Management, LLC 2.91% · 2.14M sh
Millennium Management LLC 2.42% · 1.78M sh
Wellington Management Group 2.39% · 1.76M sh
Nordea Investment Management AB 2.51% · 1.84M sh
UBS Asset Management 2.17% · 1.59M sh
Invesco Capital Management LLC 2.20% · 1.62M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 33 buys · 10 sells

NameRoleStake
Eric Ashleman Chief Executive Officer 0.08%
David Parry Former Independent Director 0.03%
Sean Gillen Senior Vice President 0.03%
Katrina Helmkamp Independent Non-Executive Chairperson 0.01%
Abhishek Khandelwal Former Senior Vice President 0.01%
Tara Tereso Senior VP & Group Executive of Health and Science Technologies (HST) 0.01%
Akhil Mahendra Officer 0.01%
Livingston Satterthwaite Former Independent Director 0.01%
Lisa Anderson Senior VP, General Counsel, Chief Administrative Officer & Corporate Secretary 0.01%
Allison Lausas Vice President 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-15 Tara Tereso Senior VP & Group Executive of Health and Science Technologies (HST) Sale to Issuer -290 $222.84
2026-09-15 William Simmons -- Sale to Issuer -218 $222.84
2026-09-10 Tara Tereso Senior VP & Group Executive of Health and Science Technologies (HST) Sale to Issuer -138 $221.46
2026-08-28 Allison Lausas Vice President Sale to Issuer -645 $230.28
2026-08-11 Lisa Anderson Senior VP, General Counsel, Chief Administrative Officer & Corporate Secretary Derivative Exercise and Sale -385 $93.27–238.59
2026-05-10 Eric Ashleman Chief Executive Officer Derivative Exercise and Sale -15,385 $93.27–215.81
2026-05-05 Carl Christenson Independent Director Other Acquisition +805 --
2026-05-05 Mark Buthman Independent Director Other Acquisition +805 --
2026-05-05 Katrina Helmkamp Independent Non-Executive Chairperson Other Acquisition +1,035 --
2026-05-05 Matthijs Glastra Independent Director Other Acquisition +805 --
2026-05-05 Mark Beck Independent Director Other Acquisition +805 --
2026-05-05 Stephanie Disher Independent Director Other Acquisition +805 --
2026-05-05 Alejandro Quiroz Centeno Independent Director Other Acquisition +805 --
2026-05-05 Lakecia Gunter Independent Director Other Acquisition +805 --
2026-05-05 L. Watts-Stanfield Former Independent Director Other Acquisition +805 --
2026-03-03 Roopa Unnikrishnan Former Senior VP and Chief Strategy & Innovation Officer Intent to Sell (Form 144) -4,309 $204.41
2026-02-22 Tara Tereso Senior VP & Group Executive of Health and Science Technologies (HST) Sale to Issuer -154 $207.48
2026-02-21 Eric Ashleman Chief Executive Officer Other Acquisition +9,040 --
2026-02-21 Eric Ashleman Chief Executive Officer Other Derivative Acquisition +38,165 $207.48
2026-02-19 Allison Lausas Vice President Sale to Issuer -179 $207.86

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.

IDEX Corp discussion 0 comments

Add a comment